These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28894601)

  • 1. The DESolve novolimus bioresorbable Scaffold: from bench to bedside.
    Mattesini A; Bartolini S; Sorini Dini C; Valente S; Parodi G; Stolcova M; Meucci F; Di Mario C
    J Thorac Dis; 2017 Aug; 9(Suppl 9):S950-S958. PubMed ID: 28894601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.
    Nef HM; Wiebe J; Foin N; Blachutzik F; Dörr O; Toyloy S; Hamm CW
    Int J Cardiol; 2017 Jan; 227():127-133. PubMed ID: 27863289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DESolve
    Demola P; Meucci F; Stolcova M; Mario CD; Mattesini A
    Future Cardiol; 2021 Sep; 17(6):945-951. PubMed ID: 33507091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter post-marketing evaluation of the Elixir DESolve
    Nef H; Wiebe J; Boeder N; Dörr O; Bauer T; Hauptmann KE; Latib A; Colombo A; Fischer D; Rudolph T; Foin N; Richardt G; Hamm C
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1021-1027. PubMed ID: 29508518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Tröbs M; Röther J; Schlundt C; Achenbach S; Hamm C; Nef H
    Heart Vessels; 2017 Jul; 32(7):781-789. PubMed ID: 28004176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario.
    Boeder NF; Dörr O; Koepp T; Blachutzik F; Achenbach S; Elsässer A; Hamm CW; Nef HM
    Front Cardiovasc Med; 2021; 8():696287. PubMed ID: 34195239
    [No Abstract]   [Full Text] [Related]  

  • 9. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds.
    Gunes HM; Gokdeniz T; Kizilirmak Yilmaz F; Demir GG; Guler E; Babur Guler G; Karaca O; Cakal B; Omaygenç MO; İbişoğlu E; Boztosun B
    J Interv Cardiol; 2017 Jun; 30(3):189-194. PubMed ID: 28440067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).
    Ormiston JA; Webber B; Ubod B; Darremont O; Webster MW
    EuroIntervention; 2015 May; 11(1):60-7. PubMed ID: 25680225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro performance investigation of bioresorbable scaffolds - Standard tests for vascular stents and beyond.
    Schmidt W; Behrens P; Brandt-Wunderlich C; Siewert S; Grabow N; Schmitz KP
    Cardiovasc Revasc Med; 2016 Sep; 17(6):375-83. PubMed ID: 27266902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Dream of Vascular Restoration Still Alive? A Case of 7 Years, Follow-Up After Bioresorbable Vascular Scaffold Implantation.
    Budassi S; Zivelonghi C; Muyldermans P; Agostoni P; Verheye S
    Cardiovasc Revasc Med; 2020 Nov; 21(11S):158-161. PubMed ID: 32029391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
    Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
    İbişoğlu E; Çakal S; Çakal B; Güneş HM; Boyraz B; Boztosun B
    Anatol J Cardiol; 2021 Dec; 25(12):912-919. PubMed ID: 34866586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive imaging of bioresorbable coronary scaffolds using CT and MRI: First in vitro experience.
    Hickethier T; Kröger JR; Von Spiczak J; Baessler B; Pfister R; Maintz D; Bunck AC; Michels G
    Int J Cardiol; 2016 Mar; 206():101-6. PubMed ID: 26785034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.
    Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM
    Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome.
    Nef HM; Wiebe J; Schmidt G; Möllmann H; Boeder NF; Dörr O; Bauer T; Blachutzik F; Liebetrau C; Elsässer A; Foin N; Hamm CW
    Herz; 2020 Dec; 45(Suppl 1):95-104. PubMed ID: 31209520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
    Gunes HM; Yılmaz FK; Gokdeniz T; Demir GG; Guler E; Guler GB; Karaca O; Cakal B; İbişoğlu E; Boztosun B
    Int J Cardiol; 2016 Dec; 224():388-393. PubMed ID: 27681252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent.
    Barkholt TØ; Webber B; Holm NR; Ormiston JA
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):E674-E682. PubMed ID: 31710149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.